BioTelemetry Research maintains global alliances and partnerships with leading clinical research organizations (CROs), clinical pharmacology units (CPUs), and central laboratories for cardiac, imaging, and blood pressure monitoring (BPM). Partnering strategies are thoughtfully designed to assist sponsors in obtaining best-in-class services, while minimizing any conflicts of interest.

Contact us to learn more about partnering with BioTelemetry Research.
  • Since 2008, AG Mednet has been the quality partner of choice in over 600 global clinical trials. AG Mednet’s partnership with BioTelemetry Research has resulted in projects with significantly reduced data queries, reduced burden on investigator sites, and increased site compliance. Our managed, global network ensures that all constituencies involved in a project are working in unison and have access to data and records in a timely fashion. Data integration with BioTelemetry Research's clinical trial management systems ensures that data only needs to be entered once, and that reconciliation of imaging and cardiac safety data occurs in real time. Currently, AG Mednet collects and delivers more than 40,000 exams per month coming from thousands of investigators and trial coordinators in more than 70 countries.

    AG Mednet
  • AMRA is the first in the world to transform images from a rapid, 6-minute whole body MRI scan into precise, 3D-volumetric fat and muscle measurements. AMRA’s cloud-based analysis service offers precise, automated insights that have far-reaching implications for the pharmaceutical industry, academic R&D and, soon, clinical practice. AMRA was founded in 2010 as a spin-off of the Center for Medical Image Science and Visualization (CMIV), the Department of Biomedical Engineering (IMT) and the Department of Medicine and Health (IMH) at Linköping University, Sweden. For more information, visit

  • CRF Health is the leading provider of electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials. With experience in more than 545 trials, over 100 languages and across 74 countries, CRF Health's TrialMax® eCOA solutions consistently demonstrate the industry's highest data accuracy, patient and site compliance, and patient retention. CRF Health's TrialMax eCOA solutions improve trial engagement by fitting into the lives of patients and seamlessly integrating into sites to maximize protocol compliance. Their eCOA solutions include PROs (Patient Reported Outcomes), ObsROs (Observer Reported Outcomes) and ClinROs (Clinician or Rater Reported Outcomes).

    CRF Health
  • As a founding member called Cardiocore, BioTelemetry Research was the first cardiac core lab to join the Cardiac Safety Research Consortium (CSRC). Other founding members include pharmaceutical organizations such as AstraZeneca, Daiichi-Sankyo, Eli Lilly, GSK, J&J, Pfizer, Merck, and Roche. The CSRC represents a key initial step in bringing together key constituencies to focus on cardiac safety issues during the drug development process. Using the principals of the FDA’s Critical Path Initiative, the CSRC focuses on improving the evaluative sciences, specifically in relation to cardiac safety.

    Cardiac Safety Research Consortium
  • Davita Clinical Research (DCR), a wholly owned subsidiary of DaVita HealthCare Partners Inc., uses its extensive, applied database and real-world healthcare experience to assist pharmaceutical and medical device companies in the design, recruitment, and completion of clinical trials, including retrospective, prospective, and pragmatic trials. DCR has two hospital-based clinical pharmacology units with 122 beds, and has conducted Phase I-IIa trials for more than 175 client companies over the last 30 years. DCR’s Early Clinical Research group conducts trials in both healthy normal volunteers and specialty populations, with expertise in renal and hepatic clearance studies. Their integrated clinical data analysis and reporting and onsite compounding pharmacies make them a comprehensive service provider for early clinical research.

    DaVita Clinical Research
  • Global Clinical Trials, LLC is a regional CRO, headquartered in Princeton, NJ, with full-service clinical operations in Russia, Ukraine, Bulgaria, Serbia and Romania. GCT has been performing clinical research in this growing and dynamic region since 2001, providing individualized approaches, flexible pricing, fast patient recruitment, and high quality clinical development services. Whether you are looking for full clinical support, including site selection, monitoring, project management, regulatory services, import/export, drug storage, or medical writing, or you are simply interested in a stand-alone task to address an urgent need, you can count on GCT to handle your requirements professionally and completely. GCT offers a strong understanding of both local and international regulations, as well as access to thousands of qualified sites specializing in numerous therapeutic areas. Our monitors and project managers are all certified clinicians experienced in GCP clinical research. GCT maintains strong ongoing relationships with investigators as well as officials in each country's regulatory authorities, enabling us to monitor changes in governmental regulations and any related impact on clinical research.

    Global Clinical Trials
  • BioTelemetry Research is an active member of the Metrics Champion Consortium (MCC), an open, multidisciplinary, non-profit organization comprised of biotechnology, pharmaceutical and service provider organizations. The mission of MCC is to develop, through a collaborative process, Performance Metrics within the Biotechnology and Pharmaceutical industry with the intent to jointly encourage performance improvement, effectiveness, efficiency and appropriate levels of controls for both Sponsors and Service Providers.

    Metrics Champion Consortium
  • The Mortara Certified Partner program provides expert HL7 consultation to certify adherence to the HL7 annotated ECG standard used by the FDA for collection and viewing of digital ECG studies. The certification process involves validation testing of sample annotated ECG files, followed by detailed consultation on potential syntax and format errors. Upon successful correction of any issues, Mortara provides the Certified Partner a certification letter stating adherence to the HL7 standard.

    Mortara Certified Partner
  • Myrian is a multimodality platform that processes, combines and compares medical images obtained from all types of imaging equipment (CT scans, MRI, PET, digital radiography, etc.) -- all in the same work space and with ergonomic comfort. Myrian optimizes productivity for radiologists and practitioners, making diagnoses more accurate and objective, while facilitating rigorous reading and analysis of medical images in clinical trials.

    Myrian by Intrasense
  • Precision Image Analysis (PIA) is an innovator in medical imaging post-processing for both research and clinical applications. PIA offers this cloud-based service for most imaging modalities, including cardiac magnetic resonance (CMR) and cardiac computed tomography (CCT).

    With a combined experience of over 60 years of multi-center, multi-national clinical trials and academic-based research, PIA’s technical team has processed thousands of CMRs, CTs and echocardiograms from centers around the world. PIA’s analysis protocols are designed to maximize both accuracy and reproducibility, with quality being comparable to the most precise published standards. PIA was recently awarded ISO 9001:2008 certification for its Quality Management System, demonstrating its uncompromising commitment to providing the highest quality services to its customers.

    PIA Medical
  • REKA Health (REKA) is a leading digital cardiovascular monitoring solution provider for healthcare professionals and researchers. REKA has developed an easy-to-use solution that complies with medical regulatory standards. The solution comprises medical-grade devices, computer and mobile software, and cloud-based web applications that are seamlessly integrated, making it the preferred choice by healthcare professionals for their practices, and by pharmaceutical companies for their clinical trials. REKA was founded in 2011, headquartered in Singapore, with satellite offices in New Jersey, USA and the Netherlands. Marketing under the REKA® brand, REKA has gained recognition from international practitioner communities and has established a global presence, covering Europe, North America and Asia Pacific markets.

    REKA Health
  • Worldwide Clinical Trials provides drug development solutions to the biopharmaceutical industry. We support our clients by delivering quality results – on time, on budget and always bolstered by unrivaled science and medicine.

    Worldwide Clinical Trials
  • Vitalograph is a world-leading provider of outstanding quality cardio-respiratory diagnostic devices, with over 50 years' heritage. Providing a variety of products and services to customers in clinical trials, primary care, occupational health, sports medicine, asthma management, emergency services and hospitals, our name is synonymous with spirometry around the world. As a result of this success we have recently expanded our range of products and services to include innovative solutions for the capture of cardiac data both at home and in clinic.

  • PPD is a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 13,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments.